Derm Cases · General Medicine
OSCE — Vitiligo & Pigmentation Disorders
Eight-minute OSCE station on Vitiligo & Pigmentation Disorders: focused history, examination priorities, investigations, emergency and definitive management.
On this page
Study tools
Target exams
Brief (to candidate)
You will assess a patient with a presentation consistent with Vitiligo & Pigmentation Disorders.
You have 8 minutes to take a focused history, outline examination, investigations, and management including red flags.
Clinical context
Vitiligo is an acquired autoimmune destruction of epidermal melanocytes producing well-demarcated, chalk-white (depigmented) macules and patches on the periorificial face, hands, extensor surfaces, genitalia and body folds; classified as segmental (unilateral, dermatomal, early onset, stabilises within 1 to 2 years) or non-segmental (bilateral, symmetrical, progressive). It is associated with autoimmune thyroid disease, type 1 diabetes, pernicious anaemia, Addison disease and alopecia areata, and carries a major psychological burden, especially in darker skin. Melasma (chloasma) is acquired symmetrical facial hyperpigmentation (forehead, malar cheeks, upper lip) triggered by sun exposure, pregnancy and combined oral contraceptives.[2]
Candidate tasks
- Clarify onset, severity, associated features, and red-flag symptoms.
- State focused examination priorities.
- List first-line investigations and any named score/criteria.
- Give immediate resuscitation steps.
- Outline definitive management with doses/routes where standard.
- Name complications and disposition (ward / HDU / theatre / discharge safety-net).
- Mention one special-population modifier (pregnancy, child, elderly, CKD).
Examiner checklist
| Domain | Pass behaviours |
|---|---|
| Definition | Correct working diagnosis language |
| Assessment | Focused, prioritised, red flags sought |
| Investigations | Appropriate first-line + interpretation |
| Emergency care | ABC / time-critical actions first |
| Definitive care | Specific drugs/procedures, not generic phrases |
| Safety | Well-demarcated chalk-white depigmented patches on face, hands or genitalia - vi |
| Safety | Rapidly progressive vitiligo - consider oral minipulse corticosteroids plus narr |
| Safety | Symmetrical brown facial pigmentation worsened by sun, pregnancy or OCP - melasm |
| Communication | Clear plan and safety-netting |
Model outline
Lead with the working diagnosis and life threats. Resuscitate before definitive tests when unstable. Use guideline-standard therapy with named agents and doses. Document escalation criteria and follow-up. A safe candidate is specific, structured, and never delays critical care for non-urgent imaging.[1]
References2ShowHide
- [1]Chaiyabutr C, Kunavisarut T, Wannawittayapa T, et al. Intramuscular Triamcinolone Acetonide Versus Oral Minipulse Dexamethasone in Active Vitiligo: An Observational Study J Cutan Med Surg, 2026.PMID 41459721
- [2]Ezzedine K, Eleftheriadou V, Whitton M, et al. Vitiligo. Lancet, 2015.PMID 25596811